Compound Emulsion Injection for Nausea and Vomiting

Mon, 13 Apr 2026 16:27:02 +0000
Intellectual Property

The USPTO published patent application US20260097042A1 for a compound emulsion combining aprepitant and palonosetron hydrochloride for injection. The formulation claims improved stability and enhanced patient adherence in preventing and treating nausea and vomiting. The application was filed on May 30, 2025.